Table 2.
Author, Year [Ref] | County | Study Period | Study Design | Main Characteristics of the Sample | Sample Size (% of F); Age as Mean ± SD | Attrition | Altered Food Behavior | Tool Used to Diagnose Altered Food Behavior | Validated Diagnostic Tool | n (or %) of Subjects with Food Addiction | Main Results | Funds | CoI |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aslan et al., 2020 [12] | Turkey | May 2018 and March 2019 | Ca–Co | Inpatient adult women diagnosed with breast cancer vs. cancer-free adult women enrolled in a primary health center | Ca: 238; 49.0 ± 9.8 y Co: 164; 47.6 ± 12.5 y |
0 | Orthorexia nervosa | ORTO-15 | yes | Ca: 23.3% Co: 6.7% | Risk of orthorexia was higher for those with a higher educational level (university degree), receiving care support, presence of a chronic disease other than cancer, and a diet that includes eating organic foods. | ns | no |
Bobonis Babilonia et al., 2020 [39] | USA | ns | Case report | Elite athletes with acute lymphoblastic leukemia | 30 y (sex not specified) | na | Orthorexia nervosa | ORTO-15 | yes | na | The desire to eat “healthy” (with juicing and a daily meal) reported as “normal” led to weight loss, malnutrition, interpersonal and sports-related impairments. | ns | no |
Cohen et al., 2018 [40] | USA | October 2015 and April 2017 | RCT assessing the role of KD vs. ACS on physical and mental health, including food cravings | Women diagnosed with ovarian or endometrial cancer | 45; 60.2 (31–79 y) | 28 | Food craving | FCI | yes | na (mean values were reported) | At 12 weeks after the intervention, the KD group reported less frequent cravings for starchy foods and fast food than the ACS group. The KD group reported less frequent cravings for starchy foods, sweets, fast food, and overall cravings at 12 weeks when compared to baseline. No within-group differences for the ACS group. | yes | no |
Dogansen et al., 2019 [41] | Turkey (11 tertiary referral centers) | ns | Multicenter CS | Adult patients with prolactinoma receiving DA for at least three months | 308 (70.1% F); 36 ± 12 y | 0 | Compulsive eating | QUIP | yes | 9 (2.9% all F) | A higher QUIP score was associated with smoking, alcohol consumption, a gambling history, and a higher nadir prolactin level. | no | no |
Martinkova et al., 2011 [14] | Slovakia | January–December, 2009 | CS | Inpatient adults with pituitary adenomas who were taking DA | 20 (50% F); 41.3 ± 11.0 y | 0 | Compulsive eating | MIDI | yes, based on DSM-IV criteria | 1 (5% M) | Compulsive eating, especially at night, which resulted in a weight gain of 20 kg in two years. High prolactin level (16,193 ng/mL) | ns | ns |
Shams-White et al., 2016 [13] | USA | ns | Co (12-month FU) | Young survivors of pediatric acute lymphoblastic leukemia (ALL) and lymphoma | 22 (32% F); 11.7 (4.7–24.9) y | Food craving | FCI | yes | na (mean values were reported) | Patients diagnosed at an older age had more frequent cravings overall and for each of the subscales: fast food, sweets, carbohydrates, and fats. | yes | no | |
Vance, Campbell et al., 2017 [42] | Canada | ns | CS | Women with stage I–IIIA breast cancer within 12 months of completing chemotherapy treatment | 28 (100%); 48.9 ± 8.5 | 0 | Food craving | Semi-structured qualitative interview | ns | 6 (50%) women who gained weight during treatment | Almost half the women who gained weight during treatments recalled that they ate more frequently and preferred starchy, carbohydrate-rich foods and others (ice cream, chocolate milk, citrus fruits, and cheese). | yes | no |
ACS: American Cancer Society diet; Ca-Co: case–control study; C: cohort study; CoI: conflict of interest; CS: cross-sectional study; DA: dopamine agonists; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; F: female; FCI: Food Cravings Inventory; FU: follow-up; M: male; MIDI: Minnesota Impulse Disorder Interview; n: number; na: not available; ns: not specified; ORTO-15: Orthorexia Nervosa scale; QUIP: Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s disease form; RCT: randomized clinical trial SD: standard deviation; USA: United States of America; y: years.